Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

Summary

The purpose of this trial is to obtain a pharmacokinetic profile (i.e. amount of drug in the blood over time) of Omecamtiv mecarbil in patients with stable heart failure.

Timeline

Start

2010-07

Primary completion

2011-05

Completion

2011-05

Outcome

Outcome not reported

Stopped: “Study cancelled due to sponsor's decision to redesign the study”

Drugs

Indications